Skip to content

Studying antithyroglobulin antibodies in hashimotos disease with murphy repertory

A clinical study in assessing the antithyroglobulin antibody levels in hashimotos thyroiditis using Murphy repertory - NIL

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2024/03/063729
Enrollment
30
Registered
2024-03-06
Start date
Unknown
Completion date
Unknown
Last updated
2024-04-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: E063- Autoimmune thyroiditis

Interventions

Intervention1: Homoeopathic medicine: 1. Case taking, medicine selection and administration will be done according to homoeopathic principle. 2. Homeopathic medicine will be selected with the help of

Sponsors

Nil
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Patients suffering from Hashimoto’s thyroiditis with elevated TSH, anti-Thyroglobulin Ab. Female patients will be included. Patients between 18-60 years of age.

Exclusion criteria

Exclusion criteria: Pregnant, post-partum and nursing women will be excluded. Known cases of other autoimmune disorders. Known cases of thyroid malignancy.

Design outcomes

Primary

MeasureTime frame
The efficacy of Homoeopathic medicines in reducing the Anti-thyroglobulin antibody level in Hashimoto’s thyroiditis will be proved before and after an interval of 6 months of the treatment. Cases will be evaluated for age, sex, occupation, symptoms presented, values of anti-thyroglobulin antibody (anti-Tg), thyroid peroxidase antibodies and TSH will be considered for statistical analysis and to derive the result, thereby validating the study.Timepoint: The efficacy of Homoeopathic medicines in reducing the Anti-thyroglobulin antibody level in Hashimoto’s thyroiditis will be proved before and after an interval of 6 months of the treatment. Cases will be evaluated for age, sex, occupation, symptoms presented, values of anti-thyroglobulin antibody (anti-Tg), thyroid peroxidase antibodies and TSH will be considered for statistical analysis and to derive the result, thereby validating the study.

Secondary

MeasureTime frame
The symptomatic improvement of the patient with hypothyroidism assessed by Zulewski clinical score will reveal the efficacy of Murphy repertory in the treatment of Hashimoto’s thyroiditis. An alphabetical repertory will be constructed on thyroid disorders.Timepoint: Medicines given will be observed for 2 weeks consecutively for 6 months

Countries

India

Contacts

Public ContactDr Reshma JR

Sarada Krishna Homoeopathic Medical College

hodcr@skhmc.org9443558483

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026